Speaking on the sidelines of the J.P. Morgan Healthcare Conference, Novo business development executive Tamara Darsow said the company is gunning for obesity and diabetes assets.
JPM26: Deal Hungry Novo Moves With ‘Intention’ To Put Metsera in the Rearview